Melanoma Skin Cancer Stats 2025 Reveal A Worrying Trend
Melanoma skin cancer statistics for 2025 show a major cancer burden in the United States: the American Cancer Society estimates nearly 105,000 invasive cases, over 107,000 melanoma in situ cases, and more than 8,400 deaths in the same year. Those figures make melanoma one of the most closely watched skin cancer trends in 2025, because it is far less common than non-melanoma skin cancers but causes a disproportionate share of deaths.
What the 2025 numbers say
The headline story in 2025 is that melanoma remains common, but outcomes are better than they were a generation ago. Recent estimates project 104,960 invasive cases and 107,240 in situ cases in the United States, for more than 212,000 total diagnoses in a single year. The projected death toll is about 8,430, underscoring why melanoma remains the deadliest form of skin cancer despite representing only about 1% of all skin cancers.
Experts were not surprised by the continued high case count, but they were encouraged by the improving survival profile. In the most recent large estimates, overall 5-year survival for non-Hispanic White patients improved from 82% in the 1975-1997 period to 94% in the 2014-2020 period. That shift reflects earlier detection, better staging, and major treatment advances in advanced melanoma.
| Measure | 2025 estimate | Why it matters |
|---|---|---|
| Invasive melanoma cases | 104,960 | Measures the number of cancers most likely to require treatment beyond removal of a superficial lesion. |
| Melanoma in situ cases | 107,240 | Shows how often melanoma is found at an earliest, non-invasive stage. |
| Total melanoma diagnoses | 212,200+ | Combines invasive and in situ disease to show overall burden. |
| Melanoma deaths | 8,400+ | Represents the mortality burden that makes melanoma especially serious. |
Age and sex patterns
The 2025 data continue a familiar pattern: melanoma incidence varies sharply by age and sex. In people under 50, rates have been stable among women and have declined by about 1% per year in men since the early 2000s. In adults 50 and older, rates have continued to rise in women by about 3% per year, while remaining stable in men in recent years. These differences matter because the disease is not evenly distributed across the population, and the risk profile changes with age and behavior.
Melanoma is also not only a disease of older adults. It remains one of the more common cancers in young adults, especially young women, and it can appear even in teens and children. A 2025 melanoma fact sheet notes that the incidence in people under 30 has increased faster than in any other age group over the long term, which keeps prevention campaigns focused on sun protection, tanning avoidance, and early recognition of suspicious lesions.
Survival and stage
Survival depends heavily on stage at diagnosis, which is why screening and prompt evaluation are so important. When melanoma is local at diagnosis, 5-year survival is greater than 99%; when it has spread regionally, survival is about 75%; and when it is distant metastatic disease, 5-year survival falls to around 35%. Put plainly, the stage at diagnosis is the strongest predictor of outcome in melanoma.
SEER training materials summarize melanoma survival this way: 5-year relative survival is 100% for stage 0, 97.6% for localized stage I-II disease, 60.3% for regional stage III disease, and 16.2% for distant stage IV disease. The same source reports that about 83% of melanomas are diagnosed at a localized stage, which helps explain why population-level survival has improved even though the number of diagnoses remains high.
"The biggest public-health opportunity in melanoma is still early detection," is the practical takeaway from current surveillance data, because survival falls dramatically once the disease moves beyond the skin.
Who is most at risk
Risk is not the same across all groups. Lifetime risk is highest in White populations and substantially lower in Black, Hispanic, and Asian/Pacific Islander populations, although melanoma can and does affect every racial and ethnic group. A recent fact sheet estimates lifetime risk at about 1 in 33 for White people, 1 in 200 for Hispanic people, and 1 in 1,000 for Black people, while the relative burden is amplified by later detection in some lower-risk groups.
Sun exposure remains the dominant modifiable risk factor. Recent melanoma summaries estimate that about 93% of melanomas are thought to be related to UV exposure and sunlight, and repeated blistering sunburns in adolescence or early adulthood substantially raise risk. Indoor tanning is also a major driver of preventable cases, which is why public-health messaging continues to focus on shade, clothing, sunscreen, and avoiding tanning beds altogether.
- UV exposure remains the leading preventable cause of melanoma.
- Blistering sunburns, especially in youth, raise long-term risk.
- Indoor tanning increases the chance of melanoma and should be avoided.
- Fair skin, many moles, family history, and prior melanoma raise risk further.
What changed by 2025
The most notable 2025 shift is that melanoma statistics now show a dual reality: high incidence and improving survival. That combination usually means detection is improving and treatments are working better, but it also means the underlying exposure and risk patterns are still generating large numbers of new cases. In other words, the country is doing better at keeping people alive after melanoma, but not yet good enough at preventing the disease in the first place.
Another important context point is that melanoma incidence is not rising uniformly everywhere. Some regions report stabilization or slower growth in certain groups, while older women still show increasing rates in several datasets. This makes 2025 a year defined less by a single national trend line and more by a patchwork of risk, detection, and survival patterns.
Practical prevention points
- Use broad-spectrum sunscreen with SPF 30 or higher every day on exposed skin.
- Avoid indoor tanning completely.
- Seek shade and limit direct midday sun exposure.
- Wear hats, sunglasses, and protective clothing outdoors.
- Check your skin regularly and get changing moles examined quickly.
These steps are especially relevant because melanoma is highly treatable when found early. The public-health message in 2025 is not simply that melanoma remains dangerous; it is that the combination of early detection and prevention can meaningfully change the outcome. That is why the latest statistics are used not just to measure disease burden, but to guide behavior and screening priorities.
Why these statistics matter
The 2025 melanoma numbers are more than a tally of diagnoses and deaths; they point to where prevention, public education, and clinical vigilance matter most. If incidence stays high while survival improves, that usually means medicine is helping more people live longer after diagnosis, but the broader exposure problem has not been solved. The strongest signal in the data is simple: early detection saves lives, and sun-safe behavior still has room to prevent thousands of future cases.
Everything you need to know about Melanoma Skin Cancer Statistics 2025
How common is melanoma in 2025?
In the United States, melanoma is expected to exceed 212,000 total diagnoses in 2025, including about 105,000 invasive cases and 107,000 in situ cases. That makes melanoma a major cancer burden even though it accounts for a relatively small share of all skin cancers.
How many people will die from melanoma in 2025?
Current 2025 estimates project more than 8,400 deaths from melanoma in the United States. Deaths remain far lower than total diagnoses, but melanoma still causes a large majority of skin cancer deaths.
Is melanoma getting more common?
In some age and sex groups, yes. Rates have continued to rise in women aged 50 and older, while younger men have seen declines and younger women have been more stable in recent years, showing that the trend is uneven rather than universal.
What is the survival rate for melanoma?
Survival depends on stage. Localized melanoma has an excellent outlook, regional disease has a much lower survival rate, and distant metastatic melanoma has the poorest prognosis, which is why early diagnosis remains critical.
Who is most likely to get melanoma?
Risk is highest in White populations, older adults, people with a history of sunburns or tanning bed use, and those with a personal or family history of melanoma. However, melanoma can occur in all racial and ethnic groups and at every adult age.